Corporate Breaking News
Corporate Breaking News
Home : Mayne Pharma launches BAC 300 capsules in the United States
May 22
2020

Mayne Pharma launches BAC 300 capsules in the United States

ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg in the United States. Mayne Pharma received approval from the US Food and Drug Administration...
Source:https://www.prnewswire.com:443/news-releases/mayne-pharma-launches-bac-300-capsules-in-the-united-states-301064172.html
 
Related News
» Hikma receives FDA approval for its generic Vascepa®
» Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap